Clinical Practice Guideline - Cholesterol Screening and Management
| Topic: Cholesterol Screening and Management |
Date of Origin: April 1998 |
| Revised/Effective Date: May
2008 |
Next Review Date: May
2010 |
Recommendation Summary:
Asuris supports the recommendations
from the Third report of the National Cholesterol
Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol
in Adults - Adult Treatment Panel III (NCEP-ATP
III). The reccomendatons from the US Preventive
Services Task Force are currently out of date
(last updated 2001), but are currently being
updated.
Web Site Link:
Key Points:
The ATP-III recommends screening and treatment
of lipid disorders. Adults should receive
the recommended cholesterol screenings at the
age and frequency as recommended by the ATP-III.
Asuris Resources:
Washington PEBB members with increased cholesterol
are eligible for participation in the cardiac
disease management program. All other Asuris
members please check your benefits to determine
eligibility for the disease management programs.
Guideline Adoption and Recommended
Use:
This guideline has been adopted based on nationally
recognized sources. This guideline is based
on the most recent medical evidence or a consensus
on clinical treatment patterns by physicians
in the selected field of practice. Asuris
adopts guidelines to help practitioners and members
make decisions about appropriate health care
for specific medical conditions. Guidelines
are not a substitute for the advice of a physician.
Benefit Determination:
Benefit determinations should be based in all
cases on the applicable contract language. To
the extent that there are any conflicts between
these guidelines and the contract language, the
contract language will control.
Back to Index 
|
